WASHINGTON, March 30 -- The U.S. Department of Health and Human Services National Institutes of Health has issued a funding opportunity announcement for the development of regulated therapeutic and diagnostic solutions for patients affected by opioid and stimulants use disorders. The agency description of the grant states: "This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) proposing research pr more ST